Eye color genetics not so simple, study finds
Researchers have identified 50 new genes for eye color in a study involving the genetic analysis of almost 195,000 people across Europe and Asia.
Smartphones could help to prevent glaucoma blindness
Smartphones could be used to scan people's eyes for early-warning signs of glaucoma - helping to prevent severe ocular diseases and blindness, a new study reveals.
When to resume exercise after an eye surgery or injury
It is common to wonder how eye surgery or an eye condition will impact your fitness routine. While it’s important to stay active, some exercise may do more harm than good.
Genetic discovery gives insight into causes of eye disease
Researchers have identified an additional seven regions in the human genome that increase the risk of developing MacTel (macular telangiectasia type 2), including a rare DNA mutation in the PHGDH gene, which will help clinicians to better diagnose and treat it.
Eye injuries cost the NBA $2.4 million in single season
Basketball remains the leading cause of sports-related eye injuries in the United States. But getting athletes of any age or skill level to wear protective eyewear is a tough sell.
Should you be worried about blue light?
When you stare at a screen for hours at a time, whether it is a computer, TV, phone or tablet, you are exposed to blue light from the device. Alarmist headlines claim blue light from too much screen time is blinding us.
Is driving performance impacted in younger patients with glaucoma?
A study published in the International Journal of Ophthalmology observed that young and middle-aged patients with glaucoma with binocular visual field loss suffered from a longer delay of response in a driving simulation test.
Study: sore eyes a common symptom in COVID-19 patients
Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.
Developments in glaucoma offering hope, options
Research has provided a fuller understanding of the role of Schlemm’s canal, tissue stiffness, and specifically the importance of flow beyond Schlemm’s canal through the ostia into the collector channels and ultimately the episcleral veins.
Remyelinating drug could improve vision in patients with multiple sclerosis
A team led by a biomedical scientist at the University of California, Riverside, reports a drug—an estrogen receptor ligand called indazole chloride (IndCl)—has the potential to improve vision in patients with multiple sclerosis, or MS.